CellR4 (Cellular Repair, Replacement, Regeneration & Reprogramming – e-ISSN: 2329-7042, Verduci International; Editor-in-Chief: Prof. Monica Montopoli) serves as a multidisciplinary, cross-platform “open source” e-journal which seeks articles related to the field of medicine, spanning from fundamental new discoveries in basic science to translational research (“bench-to-bedside”), methods and protocols, clinical trials, and identification of novel therapeutic targets. CellR4 publishes brief communications, case reports, case reports and literature review, clinical protocols, clinical trials, commentaries and perspective articles, conference proceedings, editorials, letters to the Editor, meta-analyses, meeting reports, opinion papers, original articles, systematic reviews, reviews, standard methods and operating procedures. CellR4 also serves as a trusted and authoritative platform aimed to discuss challenges and opportunities on the path to development, delivery, and clinical application of novel therapeutic options for a wide range of diseases. Topics covered by the journal include, but are not limited to, pharmacological studies, cell-based therapies, organ replacement therapies, tissue engineering, cellular reprogramming mechanisms and technologies, and regenerative pharmacology.
Articles are published on an ongoing basis through a continuous publication model. All full-text articles published in CellR4 are freely available to readers. Moreover, CellR4 covers publications on regulatory, legal and ethical issues, and welcomes submissions regarding global collaborative platforms and funding opportunities related to the field of regenerative medicine. CellR4 offers authors quick review and decision times and global distribution for their research via its open access format. CellR4 evaluates the scientific methods of each article for validity and accepts articles solely on the basis of the research quality. All articles are rigorously peer-reviewed and professionally copyedited and typeset to ensure quality. Articles are posted online as soon as they have completed the production process in a fully citable form associated with a universal digital object identifier (DOI).
CellR4 is grateful to its Editorial Board members, who are internationally-recognized experts in the field of regenerative medicine affiliated with the most prestigious Universities and Institutions in the US, Europe and Asia. Please note that any future editorial compensation will be donated to The Cure Alliance and Fondazione Cure Alliance Onlus, in support of their strategic mission. We are looking forward to receiving high-quality scientific contributions to the journal.